Taiwan Advanced Nanotech Inc. (TPEX:6797)
12.10
+0.10 (0.83%)
Aug 26, 2026, 1:59 PM CST
Taiwan Advanced Nanotech Revenue
Taiwan Advanced Nanotech had revenue of 87.49M TWD in the half year ending December 31, 2025, a decrease of -18.49%. This brings the company's revenue in the last twelve months to 170.57M, down -0.89% year-over-year. In the year 2025, Taiwan Advanced Nanotech had annual revenue of 154.37M, down -21.87%.
Revenue (ttm)
170.57M
Revenue Growth
-0.89%
P/S Ratio
2.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
360.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 154.37M | -43.22M | -21.87% |
| Dec 31, 2024 | 197.59M | -48.02M | -19.55% |
| Dec 31, 2023 | 245.61M | -1.08B | -81.48% |
| Dec 31, 2022 | 1.33B | -601.86M | -31.21% |
| Dec 31, 2021 | 1.93B | 209.31M | 12.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 2.86B |
| EPS Bio Technology | 418.74M |
| Radiant Innovation | 409.16M |
| Health & Life | 400.09M |
| Wiltrom | 314.09M |
| S&S Healthcare Holding | 172.45M |
| PlexBio | 137.57M |
| AmCad BioMed | 28.60M |